Skip to content
healthcare.dev

Cystagon

NDC 0378-9045, cysteamine bitartrate, capsule, from Mylan Pharmaceuticals Inc..

Product NDC
0378-9045
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020392
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-9045 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYSTEAMINE BITARTRATE150 mg/1

Pharmacologic classes

Cystine Depleting Agent [EPC]; Cystine Disulfide Reduction [MoA]

Package NDCNDC-11Package
0378-9045-0500378904505500 CAPSULE in 1 BOTTLE, PLASTIC (0378-9045-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f495b76d-96c6-48e5-8fa3-30a4336628eb

Use it

Look up 0378-9045 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-9045 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-9045. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.